KMDA
HEALTHCAREKamada Ltd
$8.28+0.07 (+0.85%)LIVE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving KMDA Today?
No stock-specific AI insight has been generated for KMDA yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$6.31$9.07
$8.28
Fundamentals
Market Cap$479M
P/E Ratio23.7
EPS$0.35
Dividend Yield0.03%
Dividend / Share$0.25
ROE0.1%
Profit Margin0.1%
Debt / Equity—
Trading
Volume19K
Avg Volume (10D)—
Shares Outstanding57.7M
KMDA News
20 articles- Stay Ahead of the Game With Kamada (KMDA) Q1 Earnings: Wall Street's Insights on Key MetricsYahoo Finance·May 8, 2026
- Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026Yahoo Finance·May 6, 2026
- Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to ShareholdersYahoo Finance·Mar 31, 2026
- Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, TexasGlobeNewswire Inc.·Mar 26, 2026
- Midday Fly By: IEA to release 400M oil barrels, Oracle reports Q3 beatYahoo Finance·Mar 12, 2026
- Kamada Ltd (KMDA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic OutlookYahoo Finance·Mar 11, 2026
- Kamada Q4 Earnings Call HighlightsMarketbeat·Mar 11, 2026
- Kamada (KMDA) Q4 Earnings: How Key Metrics Compare to Wall Street EstimatesYahoo Finance·Mar 11, 2026
- Kamada (KMDA) Q4 Earnings and Revenues Miss EstimatesYahoo Finance·Mar 11, 2026
- Kamada: Q4 Earnings SnapshotYahoo Finance·Mar 11, 2026
- Kamada Reports Record Top- and Bottom-line 2025 Financial Results and Affirms 2026 Guidance Representing Continued Double-Digit Organic Profitable GrowthYahoo Finance·Mar 11, 2026
- Kamada Declares Cash Dividend of $0.25 Per Share, to be Paid in Accordance with an Adopted Annual Cash Dividend PolicyYahoo Finance·Mar 11, 2026
- Ahead of Kamada (KMDA) Q4 Earnings: Get Ready With Wall Street Estimates for Key MetricsYahoo Finance·Mar 6, 2026
- KMDA vs. ARGX: Which Stock Is the Better Value Option?Yahoo Finance·Mar 5, 2026
- Kamada to Announce Fiscal Year and Fourth Quarter 2025 Financial Results on March 11, 2026Yahoo Finance·Mar 4, 2026
- KMDA or TECH: Which Is the Better Value Stock Right Now?Yahoo Finance·Feb 17, 2026
- Are Investors Undervaluing Kamada (KMDA) Right Now?Yahoo Finance·Feb 17, 2026
- Discover 3 Undiscovered Gems in Middle East StocksYahoo Finance·Jan 30, 2026
- Kamada (KMDA) Soars 8.1%: Is Further Upside Left in the Stock?Yahoo Finance·Jan 27, 2026
- Kamada Provides 2026 Annual Guidance of $200 - $205 Million in Revenues and $50 - $53 Million of Adjusted EBITDA, Representing Double-Digit Growth and Affirms 2025 Financial GuidanceYahoo Finance·Jan 7, 2026
All 20 articles loaded
Price Data
Open$8.32
Previous Close$8.21
Day High$8.35
Day Low$8.21
52 Week High$9.07
52 Week Low$6.31
52-Week Range
$6.31$9.07
$8.28
Fundamentals
Market Cap$479M
P/E Ratio23.7
EPS$0.35
Dividend Yield0.03%
Dividend / Share$0.25
ROE0.1%
Profit Margin0.1%
Debt / Equity—
Trading
Volume19K
Avg Volume (10D)—
Shares Outstanding57.7M
About Kamada Ltd
Kamada Ltd. develops, produces and markets plasma-derived protein therapies for orphan indications. The company is headquartered in Rehovot, Israel.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—